Chauvin Pharmaceuticals

Chauvin Pharmaceuticals is a specialized pharmaceutical company focused on the development and manufacture of ophthalmic products. Based in the United Kingdom, the company is widely recognized for its Minims range of preservative-free, single-dose eye drops used in diagnostic and therapeutic procedures. Since its acquisition by Bausch + Lomb in 1997, Chauvin has operated as a key subsidiary within their global vision care portfolio. Its product line includes treatments for glaucoma, ocular infections, and inflammatory conditions. The company maintains a significant presence in the European market, providing essential tools for ophthalmologists and optometrists. Chauvin continues to be a trusted name in eye care, particularly for clinical and surgical applications.